SERPINE1 and Insulin resistance: Our findings of improved insulin resistance in this pediatric cohort are in accordance with previous studies in adults in which treatment with losartan reduces insulin resistance.[20] Losartan treatment is thought to improve insulin resistance through direct effects on the RAS system [20] rather than suppression of PAI-1, which is consistent with our results.